Sohag University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Sohag Egypt (2006)

Organization Overview

First Clinical Trial
2012
NCT01600612
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

a lecturer of pathology, Sohag faculty of medicine | Associate professor, dept. of Obstetrics & gynecology, Sohag University, Egypt | Bahaa Mohammed Refaie | Department of obstetrics and Gynecology, Sohag university, Egypt | Department of Obstetrics and Gynecology, Sohag university, Egypt | Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University | Faculty of medicine sohag university | Faculty of Medicine, Sohag University | Faculty of Medicine, Sohag University, Egypt. | Lecturer of anesthesia and ICU sohag university | Lecturer of ENT sohag university | Mohamed Youssef Mohamed | Pediatrics Department, Faculty of Medicine, Sohag University | Qena Oncology Center | Qena Oncology Center- Sohag University | Sohag Faculty of medicine | Sohag Faculty of Medicine | Sohag Faculty of Medicine, Sohag university | Sohag Faculty of Medicine, Sohag University | Sohag University | Sohag university- Faculty of Medicine | Sohag University Hospital | sohag univesity hospitals

Active Ingredients

Drugs in Phase 4 Trials (25)

aciclovir (zovirax) (1 trial)

bupivacaine (Exparel) (11 trials)

dexamethasone (1 trial)

ethanol (1 trial)

gabapentin (neurontin) (1 trial)

hyaluronic acid (1 trial)

hydroxypropyl cellulose (1 trial)

insulin human (humulin) (1 trial)

insulin lispro (humalog) (1 trial)

levobupivacaine (chirocaine) (1 trial)

lidocaine (xylocaine) (5 trials)

minoxidil (loniten) (1 trial)

morphine (3 trials)

ombitasvir (Viekira Pak) (2 trials)

paritaprevir (viekira pak) (2 trials)

polyethylene glycol (1 trial)

pregabalin (lyrica) (1 trial)

propylene glycol (2 trials)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

ribavirin (virazole) (2 trials)

ritonavir (Norvir) (2 trials)

tacrolimus (prograf) (2 trials)

tetryzoline (1 trial)

triamcinolone (kenalog) (3 trials)

vitamin e (1 trial)

Drugs in Phase 3 Trials (12)

cobalamin (1 trial)

dapoxetine (priligy) (2 trials)

folic acid (1 trial)

hyaluronidase (human recombinant) (Hylenex) (1 trial)

hydrogen peroxide (1 trial)

latanoprost (xalatan) (1 trial)

multivitamins (1 trial)

platelet-rich plasma (2 trials)

potassium hydroxide (1 trial)

progesterone (progestasert) (1 trial)

tadalafil (cialis) (1 trial)

terbinafine (lamisil) (1 trial)

Drugs in Phase 2 Trials (8)

hydrocortisone (solu-cortef) (1 trial)

ketorolac (acuvail) (3 trials)

levetiracetam (keppra) (1 trial)

magnesium sulfate (Tis-U-Sol) (3 trials)

midazolam (versed) (1 trial)

myoinositol (1 trial)

sildenafil (viagra) (1 trial)

vitamin c (1 trial)

Drugs in Phase 1 Trials (5)

doxorubicin (Doxil) (1 trial)

dydrogesterone (gynorest) (1 trial)

estradiol (progynon depot) (1 trial)

ketamine (ketalar) (2 trials)

sitagliptin (januvia) (1 trial)

Drugs in Other Trials (24)

acetaminophen (tylenol) (1 trial)

atropine (1 trial)

bleomycin (blenoxane) (1 trial)

carbetocin (Pabal) (2 trials)

copper (cu-7) (1 trial)

daclatasvir (daklinza) (1 trial)

dexmedetomidine (precedex) (1 trial)

digoxin (lanoxin) (1 trial)

epinephrine (levophed) (1 trial)

fentanyl (Innovar) (1 trial)

fluorouracil (efudex) (2 trials)

furosemide (lasix) (1 trial)

granisetron (kytril) (1 trial)

misoprostol (cytotec) (1 trial)

nalbuphine (nubain) (1 trial)

ondansetron (zofran) (1 trial)

oxytocin (syntocinon) (2 trials)

pentoxifylline (trental) (1 trial)

procyanidin (2 trials)

selenium (1 trial)

silver nanoparticles (1 trial)

silymarin (1 trial)

simeprevir (olysio) (1 trial)

sofosbuvir (sovaldi) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Alopecia (Phase 4)

Alopecia Areata (Phase 4)

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 4)

Coinfection (Phase 4)

Hypertension (Phase 2)

Hypertension, Pulmonary (Phase 2)

Infertility (Phase 4)

Inflammation (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Persistent Fetal Circulation Syndrome (Phase 2)

Premature Birth (Phase 3)

Premature Ejaculation (Phase 3)

Spondylarthritis (Phase 4)

Vitiligo (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 56
  • # of Trial APIs: 74